Idexx Laboratories | IDXX - Selling And Administration Expenses

Stock Price
586.37
Daily Change
12.55 2.19%
Monthly
-6.36%
Yearly
38.83%
Q1 Forecast
556.49

Idexx Laboratories reported $275.68M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Accuray USD 127.32M 500.16M Sep/2025
Align Technology USD 441.68M 23.88M Dec/2025
AngioDynamics USD 35.99M 14K Feb/2025
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Fujifilm JPY 215.83B 2.93B Dec/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Henry Schein USD 808M 48M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
Masimo USD 128M 11.6M Dec/2025
Neogen USD 107.5M 1.56M Sep/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Phibro Animal Health USD 78.32M 10.24M Dec/2025
ResMed USD 278.4M 19.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Steris USD 352.3M 2.6M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Zoetis USD 619M 40M Dec/2025